{"public_id":"co_a050b77131e5aa5b8170d587e6f7fe08","status":"active","merged_into_public_id":null,"resolved_public_id":"co_a050b77131e5aa5b8170d587e6f7fe08","name":"serotype 19A","description":"A pneumococcal capsular serotype included in PCV13 whose contribution to adult invasive pneumococcal disease declined during the study period.","aliases":[],"types":["serotype"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":9250770,"title":"Serotype 3 Remains the Leading Cause of Invasive Pneumococcal Disease in Adults in Portugal (2012–2014) Despite Continued Reductions in Other 13-Valent Conjugate Vaccine Serotypes","citation_count":70,"url":"https://sah.borca.ai/papers/9250770"}],"claims":[{"public_id":"cl_4d8af02fccedd2f89b95cd087db1af49","text":"The proportion of invasive pneumococcal disease caused by 13-valent pneumococcal conjugate vaccine serotypes decreased from 51% in 2012 to 38% in 2014 (p < 0.001), driven mainly by declines in serotypes 7F and 19A, while serotype 3 remained stable and was the single most frequent cause of adult invasive pneumococcal disease.","corpus_id":9250770,"url":"https://sah.borca.ai/claims/cl_4d8af02fccedd2f89b95cd087db1af49"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_a050b77131e5aa5b8170d587e6f7fe08","url":"https://sah.borca.ai/concepts/co_a050b77131e5aa5b8170d587e6f7fe08"}